BYAH

Park Ha Biological Technology Co., Ltd.
NASDAQCONSUMER DEFENSIVEHOUSEHOLD & PERSONAL PRODUCTS

Key Statistics

Market Cap
$4.73M
P/E Ratio
EPS
$-2069.00
Beta
52W High
$58.00
52W Low
$0.69
50-Day MA
$1.22
200-Day MA
$7.53
Dividend Yield
Profit Margin
0.00%
Forward P/E
PEG Ratio

About Park Ha Biological Technology Co., Ltd.

Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. The company is headquartered in Wuxi, the People's Republic of China.

Official WebsiteChinaFY End: October

Fundamentals

Revenue (TTM)$2.52M
Gross Profit (TTM)$2.38M
EBITDA$-24.04M
Operating Margin-344.80%
Return on Equity-886.00%
Return on Assets-334.10%
Revenue/Share (TTM)$4.29
Book Value$5.90
Price-to-Book0.91
Price-to-Sales (TTM)1.88
EV/Revenue0.0145
EV/EBITDA15.52
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)-15.90%
Shares Outstanding$5.93M
Float425,640
% Insiders31.55%
% Institutions0.00%

Historical Volatility

HV 10-Day
HV 20-Day
HV 30-Day
HV 60-Day
HV Rank

Latest News

Park Ha Biological Technology Co., Ltd. Announces Membership Application to Personal Care Products Council (PCPC), Aligning the Brand with International Standards and Marking a Strategic Milestone in its Expansion into Amazon North America

Wuxi, China, July 01, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) (“Park Ha Biological” or the “Company”) announced that it has formally filed a complete membership application with the Personal Care Products Council (PCPC).

GlobeNewsWire7/1/2026Neutral
Park Ha Biological Technology Co., Ltd. Announces Cooperation with Amazon to Support Its Entry into the North American Personal Care Sector and Accelerate the Implementation of Its Global Strategy

Wuxi, China, June 29, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) (“Park Ha Biological” or the “Company”) announced significant progress in its global expansion by initiating cooperation with Amazon (“Amazon”) North America and commencing full-scale preparations for entry into the North American personal care market, marking a key step toward the implementation of its overseas online business. Currently, four key tasks are advancing concurrently: store qualification registration, Amazon brand registry enrollment, establishment of a compliance framework for the North American market, and planning of localized product operation strategies. All preparatory efforts are being executed efficiently and systematically, with overall progress advancing ahead of schedule. This signifies that Park Ha Biological's online commercialization strategy in North America has entered a substantive implementation phase, laying a solid foundation for the launch of its flagship stores and sustained overseas operations.

GlobeNewsWire6/29/2026Neutral
Park Ha Biological Technology Co., Ltd. announces strategic partnership with Cloud Factory Technology Holdings Limited (02512.HK) to build an AI-driven ecosystem for the beauty industry.

Wuxi, China, June 23, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) (“Park Ha Biological” or the “Company”) announced that the Company has established a comprehensive strategic partnership with Cloud Factory Technology Holdings Limited (02512.HK), a company listed on The Stock Exchange of Hong Kong (“Cloud Factory”).

GlobeNewsWire6/23/2026Neutral
Park Ha Biological Technology Co., Ltd. Announces Closing of $2.0 Million Registered Direct Offering

Wuxi, China, June 15, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd., (NASDAQ: BYAH) an exempted company with limited liability incorporated under the laws of the Cayman Islands (the “Company”), today announced the closing of its previously announced registered direct offering with several investors for the sale and purchase of an aggregate of up to 1,133,332 of the Company's Class A ordinary shares, par value $0.001 each (the “Class A Ordinary Shares”), and pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to 200,000 Class A Ordinary Shares, at a combined purchase price of $1.50 per Class A Ordinary Share and Pre-Funded Warrant.

GlobeNewsWire6/15/2026Neutral
Park Ha Biological Technology Co., Ltd. Announces Pricing of $2.0 Million Registered Direct Offering

Wuxi, China, June 12, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd., (NASDAQ: BYAH) an exempted company with limited liability incorporated under the laws of the Cayman Islands (the “Company”), today announced that it has entered into a securities purchase agreement with several investors for the sales of the Company's securities in a registered direct offering (the “Offering”) consisting of up to 1,133,332 of the Company's Class A ordinary shares, par value $0.001 each (the “Shares”), and pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to 200,000 Class A ordinary shares (the “Warrant Shares”), at a combined purchase price of $1.50 per Share and Pre-Funded Warrant. The gross proceeds to the Company from this Offering are expected to be approximately $2.0 million.

GlobeNewsWire6/12/2026Neutral
Rosen Law Firm Encourages Park Ha Biological Technology Co. Ltd. Investors to Inquire About Securities Class Action Investigation – BYAH

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Park Ha Biological Technology Co. Ltd. (NASDAQ: BYAH) resulting from allegations that Park Ha Biological may have issued materially misleading business information to the investing public. So what: If you purchased Park Ha Biological securities you may be entitled to compensation without payment of any out of pocket fees or cos.

Business Wire4/13/2026Neutral
Rosen Law Firm Encourages Park Ha Biological Technology Co. Ltd. Investors to Inquire About Securities Class Action Investigation – BYAH

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Park Ha Biological Technology Co. Ltd. (NASDAQ: BYAH) resulting from allegations that Park Ha Biological may have issued materially misleading business information to the investing public. So what: If you purchased Park Ha Biological securities you may be entitled to compensation without payment of any out of pocket fees or cos.

Business Wire4/12/2026Neutral

More CONSUMER DEFENSIVE Stocks

Data last updated: 7/9/2026